Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct 22;56(4):2003092.
doi: 10.1183/13993003.03092-2020. Print 2020 Oct.

How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?

Laurent Bertoletti  1   2   3   4 , Menno V Huisman  5
Affiliations
Editorial

How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?

Laurent Bertoletti et al. Eur Respir J. .

Abstract

D-dimer threshold at 2590 ng·mL−1 is able to predict pulmonary embolism in COVID-19 patients with clinical deterioration https://bit.ly/3kYObc3

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: L. Bertoletti reports grants and non-financial support for meeting attendance from Bayer, grants, personal fees for advisory board work and non-financial support for meeting attendance from BMS/Pfizer, personal fees for advisory board work and non-financial support for meeting attendance from Leo Pharma and Aspen, outside the submitted work. Conflict of interest: M.V. Huisman reports grants and personal fees from ZONMW, Boehringer Ingelheim, Bayer Health Care, Pfizer-BMS and Leo Pharma, during the conduct of the study.

Comment on

  • Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
    Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, Behr J, Capellier G, Soumagne T, Pili-Floury S, Besch G, Mourey G, Lepiller Q, Chirouze C, Schiele F, Chopard R, Meneveau N. Mouhat B, et al. Eur Respir J. 2020 Oct 22;56(4):2001811. doi: 10.1183/13993003.01811-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32907890 Free PMC article.

References

    1. Guan W, Ni Z, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720. doi:10.1056/NEJMoa2002032 - DOI - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. McGonagle D, O'Donnell J, Sharif K, et al. . Immune mechanisms of pulmonary intravascular coagulopathy (PIC) in COVID-19 pneumonia. Lancet Rheumatol 2020; 2019: 1–9. - PMC - PubMed
    1. Gupta A, Madhavan M V, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017–1032. doi:10.1038/s41591-020-0968-3 - DOI - PMC - PubMed
    1. Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120–128. doi:10.1056/NEJMoa2015432 - DOI - PMC - PubMed

Substances